| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.18 |
7e-05 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.15 |
0.0008 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.001 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.001 |
| mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |